37 research outputs found

    Evaluation of Fetuses in the Preventive IVIG Therapy for Congenital Heart Block (PITCH) study

    Get PDF
    The recurrence rate of anti-SSA/Ro associated congenital heart block (CHB) is 17%. Reversal of 3rd degree block has never been achieved. Based on potential reduction of maternal autoantibody titers as well as fetal inflammatory responses, IVIG was evaluated as a preventative therapy for CHB
    corecore